Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age

por Moreira, E. D., Giuliano, A. R., de Hoon, J., Iversen, O.-E., Joura, E. A., Restrepo, J., Van Damme, P., Vandermeulen, C., Ellison, M. C., Krick, A., Shields, C., Heiles, B., Luxembourg, A.
Publicado 2017

Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries

por Garland, S M, Pitisuttithum, P, Ngan, H Y S, Cho, C -H, Lee, C -Y, Chen, C -A, Yang, Y C, Chu, T -Y, Twu, N -F, Samakoses, R, Takeuchi, Y, Cheung, T H, Kim, S C, Huang, L -M, Kim, B -G, Kim, Y -T, Kim, K -H, Song, Y -S, Lalwani, S, Kang, J -H, Sakamoto, M, Ryu, H -S, Bhatla, N, Yoshikawa, H, Ellison, M C, Han, S R, Moeller, E, Murata, S, Ritter, M, Sawata, M, Shields, C, Walia, A, Perez, G, Luxembourg, A
Publicado 2018